These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 8513718

  • 1. Symptomatic treatment of nephrotic syndrome.
    McLigeyo SO.
    East Afr Med J; 1993 Jan; 70(1):1-2. PubMed ID: 8513718
    [No Abstract] [Full Text] [Related]

  • 2. The nephrotic syndrome.
    Orth SR, Ritz E.
    N Engl J Med; 1998 Apr 23; 338(17):1202-11. PubMed ID: 9554862
    [No Abstract] [Full Text] [Related]

  • 3. Effect of dietary protein restriction and angiotensin converting enzyme inhibition on protein metabolism in the nephrotic syndrome.
    Don BR, Wada L, Kaysen GA, Schambelan M.
    Kidney Int Suppl; 1989 Nov 23; 27():S163-7. PubMed ID: 2561515
    [No Abstract] [Full Text] [Related]

  • 4. Effectiveness of dietary protein augmentation associated with angiotensin-converting enzyme inhibition in the management of the nephrotic syndrome.
    Garini G, Mazzi A, Allegri L, Buzio C, Borghetti A.
    Miner Electrolyte Metab; 1996 Nov 23; 22(1-3):123-7. PubMed ID: 8676802
    [Abstract] [Full Text] [Related]

  • 5. Congenital nephrotic syndrome.
    Jackson LW.
    Neonatal Netw; 2007 Nov 23; 26(1):47-55. PubMed ID: 17285887
    [Abstract] [Full Text] [Related]

  • 6. Congenital nephrotic syndrome responsive to captopril and indometacin.
    Heaton PA, Smales O, Wong W.
    Arch Dis Child; 1999 Aug 23; 81(2):174-5. PubMed ID: 10490532
    [Abstract] [Full Text] [Related]

  • 7. Management of steroid resistant nephrotic syndrome.
    Indian Society of Pediatric Nephrology, Gulati A, Bagga A, Gulati S, Mehta KP, Vijayakumar M.
    Indian Pediatr; 2009 Jan 23; 46(1):35-47. PubMed ID: 19179716
    [Abstract] [Full Text] [Related]

  • 8. [Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. III. Rapidly progressing glomerulonephritis and the use of converting enzyme inhibitors and non-steroidal anti-inflammatory drugs in idiopathic nephrotic syndrome].
    Klinger M, Szewczyk Z.
    Przegl Lek; 1989 Jan 23; 46(11):779-83. PubMed ID: 2623185
    [No Abstract] [Full Text] [Related]

  • 9. Proteinuria and albumin homeostasis in the nephrotic syndrome: effect of dietary protein intake.
    Rodrigo R, Bravo I, Pino M.
    Nutr Rev; 1996 Nov 23; 54(11 Pt 1):337-47. PubMed ID: 9110562
    [Abstract] [Full Text] [Related]

  • 10. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
    Tsurko VV, Preobrazhenskiĭ DV, Ob ukhova OA.
    Ter Arkh; 2003 Nov 23; 75(5):64-70. PubMed ID: 12847902
    [No Abstract] [Full Text] [Related]

  • 11. Nephrotic edema--pathogenesis and treatment.
    Palmer BF.
    Am J Med Sci; 1993 Jul 23; 306(1):53-67. PubMed ID: 8328511
    [Abstract] [Full Text] [Related]

  • 12. [To what extent can prostaglandin synthesis inhibitors of the non-steroidal antirheumatic (NSAR) type modify the effect of ACE inhibitors?].
    Grote L.
    Internist (Berl); 1995 Dec 23; 36(12):1203-4. PubMed ID: 8567229
    [No Abstract] [Full Text] [Related]

  • 13. [Nephrotic syndrome: complications and general principles of treatment].
    Tareeva IE, Poliantseva LR, Kutyrina IM.
    Klin Med (Mosk); 1994 Dec 23; 72(2):55-7. PubMed ID: 8015247
    [No Abstract] [Full Text] [Related]

  • 14. Adult nephrotic syndrome: non-specific strategies for treatment.
    Charlesworth JA, Gracey DM, Pussell BA.
    Nephrology (Carlton); 2008 Feb 23; 13(1):45-50. PubMed ID: 18199102
    [Abstract] [Full Text] [Related]

  • 15. [Nephrotoxicity of drugs].
    Paoletti V, Mammarella A, Falaschi R, Labbadia G, Donnarumma L, Musca A.
    Clin Ter; 1995 Jan 23; 146(1):49-64. PubMed ID: 7705013
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of nephrotic syndrome in adults].
    Honkanen E.
    Duodecim; 2000 Jan 23; 116(21):2355-63; quiz 2363-4, 2389. PubMed ID: 12053363
    [No Abstract] [Full Text] [Related]

  • 17. Angiotensin converting enzyme inhibitor improves nephrotic syndrome associated with cyanotic congenital heart disease.
    Watanabe Y, Fukuzawa Y, Inaguma D.
    Clin Nephrol; 1996 May 23; 45(5):362-3. PubMed ID: 8738675
    [No Abstract] [Full Text] [Related]

  • 18. High potassium. Too much of a good thing.
    Mayo Clin Health Lett; 2009 Feb 23; 27(2):6. PubMed ID: 19360981
    [No Abstract] [Full Text] [Related]

  • 19. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
    Kaysen GA, Davies RW.
    J Am Soc Nephrol; 1990 Nov 23; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
    [Abstract] [Full Text] [Related]

  • 20. Focus on proteinuria.
    Glassock RJ.
    Am J Nephrol; 1990 Nov 23; 10 Suppl 1():88-93. PubMed ID: 2256481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.